Star Imaging and Path Lab Ltd
Incorporated in 2004, Star Imaging and Path Lab Limited is a healthcare company providing diagnostic services across a wide range of medical tests.[1]
- Market Cap ₹ 153 Cr.
- Current Price ₹ 88.0
- High / Low ₹ 152 / 81.8
- Stock P/E 7.75
- Book Value ₹ 61.3
- Dividend Yield 0.00 %
- ROCE 33.7 %
- ROE 40.6 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company has a good return on equity (ROE) track record: 3 Years ROE 33.8%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 227 days.
- Working capital days have increased from 45.0 days to 124 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Part of BSE SME IPO
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 69 | 58 | 78 | 82 | |
| 54 | 52 | 56 | 53 | |
| Operating Profit | 15 | 6 | 23 | 29 |
| OPM % | 21% | 10% | 29% | 35% |
| 0 | 0 | 1 | 0 | |
| Interest | 2 | 2 | 2 | 3 |
| Depreciation | 4 | 3 | 5 | 5 |
| Profit before tax | 9 | 1 | 16 | 21 |
| Tax % | 33% | 34% | 23% | 25% |
| 6 | 1 | 12 | 16 | |
| EPS in Rs | 42.00 | 3.80 | 82.27 | 11.79 |
| Dividend Payout % | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 6% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 36% |
| TTM: | 37% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 34% |
| Last Year: | 41% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|
| Equity Capital | 2 | 2 | 2 | 14 | 17 |
| Reserves | 17 | 17 | 30 | 34 | 89 |
| 30 | 27 | 31 | 33 | 20 | |
| 10 | 16 | 19 | 18 | 22 | |
| Total Liabilities | 58 | 61 | 81 | 98 | 150 |
| 15 | 19 | 22 | 21 | 26 | |
| CWIP | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| 43 | 42 | 60 | 77 | 124 | |
| Total Assets | 58 | 61 | 81 | 98 | 150 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 14 | 6 | 18 | -6 | |
| -4 | -9 | -7 | -4 | |
| -7 | -5 | 2 | -0 | |
| Net Cash Flow | 3 | -7 | 13 | -10 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Debtor Days | 86 | 110 | 151 | 227 |
| Inventory Days | ||||
| Days Payable | ||||
| Cash Conversion Cycle | 86 | 110 | 151 | 227 |
| Working Capital Days | 6 | -12 | 23 | 124 |
| ROCE % | 6% | 33% | 34% |
Documents
Announcements
-
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Acceptance Of Request For Providing Credit/Cashless Medical Services To All Serving Officer(S)/Official(S) Of The Supreme Court Of India
14h - 07 Jan 2026: Star Imaging to provide cashless medical services to Supreme Court officers and dependents under CGHS; non-material impact.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
2d - KFin certified Reg 74(5) compliance for quarter ended Dec 31, 2025.
-
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015- Empanelment With WDRA Government Of India
2 Jan - Empanelled by WDRA to provide medical diagnostic and laboratory services at CGHS rates; empanelment valid three years.
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
13 Nov 2025 - Infomerics report: Rs55.66 crore IPO; net proceeds Rs49.67 crore; Rs17.38 crore utilized by Sep 30, 2025.
-
Unaudited (Standalone And Consolidated) Financial Results Of The Company For Half Year Ended 30Th September 2025
13 Nov 2025 - Unaudited H1 ended Sep 30, 2025: Revenue ₹4,556.40L, profit ₹1,003.35L; IPO proceeds ₹5,566.40L.
Business Profile[1]
Star Imaging and Path Lab Limited (originally Janta X-Ray Clinic) is a Delhi-based diagnostic healthcare service provider offering pathology, radiology, cardiology, and neurology services. The company operates through B2C, B2B, and B2G models, with NABL-accredited facilities.